Cargando…

Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis

OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: AbdulWahab, Atqah, Salah, Husam, Chandra, Prem, Taj-Aldeen, Saad J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530559/
https://www.ncbi.nlm.nih.gov/pubmed/28747217
http://dx.doi.org/10.1186/s13104-017-2656-z
_version_ 1783253288306606080
author AbdulWahab, Atqah
Salah, Husam
Chandra, Prem
Taj-Aldeen, Saad J.
author_facet AbdulWahab, Atqah
Salah, Husam
Chandra, Prem
Taj-Aldeen, Saad J.
author_sort AbdulWahab, Atqah
collection PubMed
description OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory volume in 1st second (FEV1). RESULTS: Candida isolates were identified by MALDI-TOF MS to species level from 40/52 (76.9%) cystic fibrosis patients. C. dubliniensis was the most common organism isolated from 50/77 (65%) lower respiratory specimens of 29 patients. Patients with persistent C. dubliniensis isolates have higher mean BMI in comparison to intermittent C. dubliniensis group. However, this difference did not reach statistical significance (P = 0.539). In contrast, patients with persistent C. dubliniensis isolates have significantly lower FEV1% mean in comparison to intermittent C. dubliniensis group particularly at initial two visits (P < 0.05); however, at subsequent visit the difference observed was not statistically significant (P = 0.456). The persistence of C. dubliniensis is more frequent in adults having more advanced disease, co-infections with chronic P. aeruginosa, cystic fibrosis related diabetes, long-term nebulized tobramycin and oral Zithromax therapy than patients with intermittent C. dubliniensis. Patients with persistent C. dubliniensis have lower FEV1 percentage and higher BMI than the intermittent C. dubliniensis.
format Online
Article
Text
id pubmed-5530559
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55305592017-08-02 Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis AbdulWahab, Atqah Salah, Husam Chandra, Prem Taj-Aldeen, Saad J. BMC Res Notes Research Note OBJECTIVES: Candida dubliniensis is an emerging yeast and demonstrated a high adherence property to cystic fibrosis respiratory tract. Therefore, it is important to determine the persistence of C. dubliniensis and to assess the possible relationship to the body mass index (BMI) and forced expiratory volume in 1st second (FEV1). RESULTS: Candida isolates were identified by MALDI-TOF MS to species level from 40/52 (76.9%) cystic fibrosis patients. C. dubliniensis was the most common organism isolated from 50/77 (65%) lower respiratory specimens of 29 patients. Patients with persistent C. dubliniensis isolates have higher mean BMI in comparison to intermittent C. dubliniensis group. However, this difference did not reach statistical significance (P = 0.539). In contrast, patients with persistent C. dubliniensis isolates have significantly lower FEV1% mean in comparison to intermittent C. dubliniensis group particularly at initial two visits (P < 0.05); however, at subsequent visit the difference observed was not statistically significant (P = 0.456). The persistence of C. dubliniensis is more frequent in adults having more advanced disease, co-infections with chronic P. aeruginosa, cystic fibrosis related diabetes, long-term nebulized tobramycin and oral Zithromax therapy than patients with intermittent C. dubliniensis. Patients with persistent C. dubliniensis have lower FEV1 percentage and higher BMI than the intermittent C. dubliniensis. BioMed Central 2017-07-26 /pmc/articles/PMC5530559/ /pubmed/28747217 http://dx.doi.org/10.1186/s13104-017-2656-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
AbdulWahab, Atqah
Salah, Husam
Chandra, Prem
Taj-Aldeen, Saad J.
Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title_full Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title_fullStr Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title_full_unstemmed Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title_short Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis
title_sort persistence of candida dubliniensis and lung function in patients with cystic fibrosis
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530559/
https://www.ncbi.nlm.nih.gov/pubmed/28747217
http://dx.doi.org/10.1186/s13104-017-2656-z
work_keys_str_mv AT abdulwahabatqah persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis
AT salahhusam persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis
AT chandraprem persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis
AT tajaldeensaadj persistenceofcandidadubliniensisandlungfunctioninpatientswithcysticfibrosis